SillaJen Inc
KOSDAQ:215600
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SillaJen Inc
Revenue
SillaJen Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SillaJen Inc
KOSDAQ:215600
|
Revenue
₩7.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Revenue
₩4.2T
|
CAGR 3-Years
22%
|
CAGR 5-Years
18%
|
CAGR 10-Years
21%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Revenue
₩14.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Revenue
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Revenue
₩215.9B
|
CAGR 3-Years
96%
|
CAGR 5-Years
38%
|
CAGR 10-Years
47%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Revenue
₩79.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
SillaJen Inc
Glance View
SillaJen, Inc. develops oncolytic immunotherapeutics virus. The company is headquartered in Seoul, Seoul. The company went IPO on 2016-12-06. The Company’s major product is Pexa-Vec, which is in a global Phase 3 clinical trial that is used for the treatment of liver cancer. Additionally, it also offers oncolytic virus immunotherapeutics, including SJ-102, SJ-103, SJ-815, JX-929, JX-930, JX-963, JX-970 and others.970 and others.
See Also
What is SillaJen Inc's Revenue?
Revenue
7.8B
KRW
Based on the financial report for Sep 30, 2025, SillaJen Inc's Revenue amounts to 7.8B KRW.
What is SillaJen Inc's Revenue growth rate?
Revenue CAGR 5Y
35%
Over the last year, the Revenue growth was 24%. The average annual Revenue growth rates for SillaJen Inc have been 25% over the past three years , 35% over the past five years .
